Correlation Between Immunovant and IVERIC Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immunovant and IVERIC Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunovant and IVERIC Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunovant and IVERIC Bio, you can compare the effects of market volatilities on Immunovant and IVERIC Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunovant with a short position of IVERIC Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunovant and IVERIC Bio.

Diversification Opportunities for Immunovant and IVERIC Bio

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Immunovant and IVERIC is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Immunovant and IVERIC Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IVERIC Bio and Immunovant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunovant are associated (or correlated) with IVERIC Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IVERIC Bio has no effect on the direction of Immunovant i.e., Immunovant and IVERIC Bio go up and down completely randomly.

Pair Corralation between Immunovant and IVERIC Bio

Given the investment horizon of 90 days Immunovant is expected to generate 3.6 times less return on investment than IVERIC Bio. In addition to that, Immunovant is 1.54 times more volatile than IVERIC Bio. It trades about 0.03 of its total potential returns per unit of risk. IVERIC Bio is currently generating about 0.19 per unit of volatility. If you would invest  1,954  in IVERIC Bio on October 10, 2024 and sell it today you would earn a total of  2,041  from holding IVERIC Bio or generate 104.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy24.24%
ValuesDaily Returns

Immunovant  vs.  IVERIC Bio

 Performance 
       Timeline  
Immunovant 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunovant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
IVERIC Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IVERIC Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, IVERIC Bio is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Immunovant and IVERIC Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immunovant and IVERIC Bio

The main advantage of trading using opposite Immunovant and IVERIC Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunovant position performs unexpectedly, IVERIC Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVERIC Bio will offset losses from the drop in IVERIC Bio's long position.
The idea behind Immunovant and IVERIC Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes